Dow Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DOW PHARM, and when can generic versions of DOW PHARM drugs launch?
DOW PHARM has nine approved drugs.
There are two US patents protecting DOW PHARM drugs.
There are six patent family members on DOW PHARM drugs in six countries and eighteen supplementary protection certificates in thirteen countries.
Summary for Dow Pharm
International Patents: | 6 |
US Patents: | 2 |
Tradenames: | 7 |
Ingredients: | 7 |
NDAs: | 9 |
Patent Litigation for Dow Pharm: | See patent lawsuits for Dow Pharm |
Drugs and US Patents for Dow Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dow Pharm | NUTRACORT | hydrocortisone | LOTION;TOPICAL | 087644-001 | Aug 24, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | RX | Yes | Yes | 11,324,710 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | RX | Yes | Yes | 10,653,656 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dow Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | 5,670,547 | ⤷ Try a Trial |
Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | 6,517,847 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dow Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 3095937 | ⤷ Try a Trial |
Brazil | 112020020431 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2019195697 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dow Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | PA2013025 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
0617614 | C300043 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.